MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
OKYO Pharma Limited Ordinary Shares

OKYO

#6046
OKYO Pharma Limited Ordinary Shares
1.71
0.00%
Sector:
Base:
Profit Currency:
Daily Range
1.71
1.71
Year Range
1.03
3.20
Daily Change
0.00%
Monthly Change
-23.32%
6 month change
-24.67%
Year Change
+44.92%
Previous Close
1.71
Open
1.71
Bid
Ask
Low
1.71
High
1.71
Volume
2
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. OKYO
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 2021202220232024 TTM

News

Investing Investing
OKYO
2026.02.20
Piper Sandler initiates OKYO Pharma stock with Overweight rating
Investing Investing
OKYO
2026.02.13
OKYO Pharma stock tumbles on $20 million public offering announcement
Investing Investing
OKYO
2026.02.13
OKYO Pharma announces $20 million public offering of ordinary shares
Investing Investing
OKYO
2026.02.11
OKYO Pharma transitions ATM equity offering to Leerink Partners as sales agent
Investing Investing
OKYO
2026.02.10
OKYO Pharma appoints former Dompé CMO Flavio Mantelli to lead NCP program
Investing Investing
OKYO
2026.01.30
OKYO Pharma to present urcosimod NCP study results at ASCRS meeting
Investing Investing
OKYO
2026.01.29
H.C. Wainwright reiterates Buy rating on OKYO Pharma stock with $7 price target
Investing Investing
OKYO
2026.01.28
OKYO Pharma stock rises after FDA confirms Phase 2b/3 trial design
Investing Investing
OKYO
2026.01.28
OKYO Pharma reports successful FDA meeting on urcosimod clinical trial
Investing Investing
OKYO
2026.01.28
OKYO Pharma receives FDA alignment on Phase 2b/3 trial for NCP treatment
Investing Investing
OKYO
2026.01.26
OKYO Pharma stock gets FDA compassionate use approval for urcosimod
Investing Investing
OKYO
2026.01.23
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd